1. Anita Kennerfalk DDS MSc, Epidemiologist, Department of Epidemiology, AstraZeneca R&D, Mölndal, Sweden; Section of Preventive Cardiology, Göteborg University, Göteborg, Sweden
2. Ana Ruigómez MD PhD, Epidemiologist, Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain
3. Mari-Ann Wallander PhD, Associate Professor, Department of Epidemiology, AstraZeneca R&D, Mölndal; Department of Public Health and Caring Science, Uppsala University, Uppsala, Sweden
4. Lars Wilhelmsen MD PhD, Professor, Section of Preventive Cardiology, Göteborg University
5. Saga Johansson MD PhD, Associate Professor, Department of Epidemiology, AstraZeneca R&D, Mölndal; Section of Preventive Cardiology, Göteborg University